P. A-M (@PAMJ84) profile picture

Ronin Haematologist

Europe
Joined March 2009
Photo by P. A-M (@PAMJ84)Photo by P. A-M (@PAMJ84)Photo by P. A-M (@PAMJ84)Photo by P. A-M (@PAMJ84)Photo by P. A-M (@PAMJ84)Photo by P. A-M (@PAMJ84)Photo by P. A-M (@PAMJ84)Photo by P. A-M (@PAMJ84)Photo by P. A-M (@PAMJ84)Photo by P. A-M (@PAMJ84)
Super proud to announce AlphaGenome 2 - our new DNA sequence model! 🧬 It predicts the impact of DNA variants in different specific cell types - unlocking crucial information for understanding complex diseases. Available for academic research via our API: alphagenomedocs.com/
Your heart, brain, and immune system share the same DNA sequence. So how can a single-letter change affect disease in some cells, while sparing the rest? AlphaGenome 2 is our new AI model that zooms in on specific cells to help scientists understand what drives disease. 🧵
216
457
82
3,610
197,920
USC Stem Cell won a $6.9 million CIRM grant to finish preclinical work on a heart muscle therapy made from stem cells. The goal is a first human safety trial in late 2027 for people with severe heart attacks (cardiogenic shock), at USC and UW. stemcell.keck.usc.edu/cirm-a…
2
11
721
BioCardia $BCDA said today it has finished consultations with Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) on the application package for its CardiAMP cell therapy system in ischemic heart failure with a target of treating its first Japanese patients in 2028. stemcelltracker.com/news/car…
1
8
761
P. A-M retweeted
The US mid-term elections swept the Democratic party to power in both chambers of the US Congress, raising hopes that lawmakers will now push back against disruptions to science introduced by the Trump administration. go.nature.com/4iw9Sib
5
42
1
87
14,978
#Empresas |🧬Syntax Bio logra dirigir células madre hacia estados similares a los de las células beta pancreáticas en solo 4 días mediante CRISPRa. ➡ Un avance prometedor para el desarrollo de terapias celulares frente a la diabetes tipo 1. 🔬 diariomedico.com/medicina/em…
1
1
241
Top indications for global cancer vaccine trials: 1. Melanoma (263) 2. Lung cancer (216) 3. Breast cancer (176) Particularly exciting to me are the cancer interception studies (aiming to prevent progression from pre-cancer to cancer) — there are 51 of those, globally.
We mapped the global landscape of cancer vaccine clinical trials. There are 1689 ongoing programs: 640 in phase 1, 786 in phase 2, and 101 in phase 3. Most of them are funded by US institutions (601 trials), followed by China (215) and Japan (141). The top indications are melanoma (263), followed by lung cancer (216) and breast cancer (176). The most common companion immunotherapy is the PD1 inhibitor, pembrolizumab, but some trials test next-gen immunotherapies, including PD1/VEGF and PDL1/TGF-β bispecifics. The full analysis is here: breakthrough.elabela.co/p/th…
3
39
3
175
21,987
Kamau Therapeutics Releases Encouraging Sickle Cell Clinical Data Ahead of ASH Meeting The findings show precise correction of the #SCD mutation in the β-globin gene in three SCD patients as well as restored expression of adult #hemoglobin (HbA) @vbarsan hubs.li/Q04DgDpy0
1
3
5
1,176
November is American Diabetes Month, a time to raise awareness of the challenges faced by those living with diabetes. At iTolerance, we're committed to advancing innovative cell therapy approaches that may transform treatment options for Type 1 diabetes. #T1D #Type1Diabetes
1
3
55
P. A-M retweeted
La Unidad de Producción de Medicamentos de Terapia Avanzada del Hospital La Paz (Madrid) busca Responsable y Técnico de Control de Calidad para su Sala Blanca. Consulta, todos los requisitos y condiciones, y aplica aquí: redteravplus.es/redterav/job…
2
1
108
P. A-M retweeted
Today we announced that initial clinical data from our ongoing Phase 1/2 study of mRNA-2808 have been selected for oral presentation at the 68th American Society of Hematology (ASH) Annual Meeting, taking place December 12–15, 2026, in New Orleans, Louisiana. Read more: accessnewswire.com/newsroom/… #ASH2026
10
3
56
6,595
RNA Modifications in Cancer Therapy Resistance: Mechanisms and Therapeutic Targeting dlvr.​it/TW9rnG #MTNA
3
6
479
🥼 Scientists conducted a first-in-human #ClinicalTrial involving a single intravenous infusion of glycocalyx-edited autologous bone marrow-derived mesenchymal stem cells in ten women with advanced-stage #osteoporosis. 🔎 Read more in @CellCellPress: bit.ly/4iVknvZ.
3
6
636
In medicine we say “recommendations as per our prior notes; thank you for this interesting consult, signing off”
This Post is from a suspended account. Learn more
7
19
294
17,488
🤝Los oncólogos en Europa (@myESMO) y EEUU (@ASCO) se alían para ❌reducir la 📃burocracia de los 🧪ensayos clínicos. 👉Estiman que los investigadores recogen entre 10 y 20 veces más información de la necesaria. diariomedico.com/medicina/on…
2
4
485